Discovery/Preclinical |

Clinical

Freeline to present new data at the 12th Annual Protein and...

Biospace News - October 30, 2020

Freeline to present new data at the 12th Annual Protein and Antibody Engineering Summit

Commercial

OSE Immunotherapeutics Presents OSE-230 as a Novel Agonist Monoclonal Antibody Therapy...

Biospace News - October 30, 2020

OSE Immunotherapeutics Presents OSE-230 as a Novel Agonist Monoclonal Antibody Therapy Triggering Resolution of Chronic Inflammation

Deals

Mytide Therapeutics Launches with Novel Platform that Automates Peptide Manufacturing and...

Biospace News - October 30, 2020

Mytide Therapeutics Launches with Novel Platform that Automates Peptide Manufacturing and Accelerates Delivery Timeline

Commercial

ERYTECH to Host Third Quarter 2020 Conference Call and Business Update...

Globenewswire News - October 29, 2020

ERYTECH to Host Third Quarter 2020 Conference Call and Business Update on November 6, 2020 Nasdaq:ERYP

Commercial

Bellicum Announces Interim BPX-601 Data and Corporate Restructuring Nasdaq:BLCM

Globenewswire News - October 29, 2020

Bellicum Announces Interim BPX-601 Data and Corporate Restructuring Nasdaq:BLCM

12 3...63 Page 1 of 63

NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…

OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…

BioSpace Movers & Shakers, Oct. 30

Q32 Stays Busy with $60 Million Series B and First Dose…

Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…

Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…

Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…

Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…

Discovery/Preclinical

NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November 12

OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the Efficacy of OLX10010 in Phase 2a Clinical Trial for Hypertrophic Scars Korean Securities...

BioSpace Movers & Shakers, Oct. 30

Q32 Stays Busy with $60 Million Series B and First Dose in Phase I Trial

BioLineRx Announces Positive Results from Interim Analysis of GENESIS Phase 3 Trial of Motixafortide (BL-8040) in Stem Cell Mobilization

Freeline to present new data at the 12th Annual Protein and...

OSE Immunotherapeutics Presents OSE-230 as a Novel Agonist Monoclonal Antibody Therapy...

Mytide Therapeutics Launches with Novel Platform that Automates Peptide Manufacturing and...

ERYTECH to Host Third Quarter 2020 Conference Call and Business Update...

Bellicum Announces Interim BPX-601 Data and Corporate Restructuring Nasdaq:BLCM

LATEST NEWS

MacroGenics Announces Departure of Chief Medical Officer

Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment of Cellulite to Be Presented at The Aesthetic Meeting 2019

EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38? Kinase Inhibitor Neflamapimod on the Neurodegenerative Process

MUST READ

Xencor to Host Fourth Quarter and Full Year 2018 Financial Results Webcast and Conference...

Hexavalent DTaP-IPV-Hib-HepB Vaccine Safe and Effective in Premature Infants: Presented at ESPID

Neos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results Nasdaq:NEOS

POPULAR POSTS

United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial...

Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial...

Ocular Therapeutix Announces FDA Approval of Supplemental New Drug Application (sNDA)...

POPULAR CATEGORY